Human tyrosinase is able to oxidize both enantiomers of rhododendrol

Pigment Cell and Melanoma Research

Volumn 27, Issue 6, 2014, Pages 1149-1153

  Ito, Shosuke ^a   Gerwat, Wolfram ^b   Kolbe, Ludger ^b   Yamashita, Toshiharu ^c   Ojika, Makoto ^d   Wakamatsu, Kazumasa ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b BEIERSDORF AG   (Germany)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Human tyrosinase; Melanocyte toxicity; Rhododendrol; Whitening agent

Indexed keywords

2 BUTANOL; LEVODOPA; MONOPHENOL MONOOXYGENASE; RHODODENDROL; TYROSINE; UNCLASSIFIED DRUG; BUTANOL;

AFFINITY CHROMATOGRAPHY; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENANTIOMER; ENZYME METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MELANOCYTE; MELANOGENESIS; OPTICAL RESOLUTION; STEREOSPECIFICITY; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; STEREOISOMERISM; TIME;

BUTANOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MONOPHENOL MONOOXYGENASE; OXIDATION-REDUCTION; STEREOISOMERISM; TIME FACTORS;

EID: 84911412519     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12300     Document Type: Article

References (15)

1. Akazawa, H., Akihisa, T., Taguchi, Y., Banno, N., Yoneima, R., and Yasukawa, K. (2006). Melanogenesis inhibitory and free radical scavenging activities of diarylheptanoids and other phenolic compounds from the bark of Acer nikoense. Biol. Pharm. Bull. 29, 1970-1972.
2. Bolton, J.L., Trush, M.A., Penning, T.M., Dryhurst, G., and Monks, T.J. (2000). Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135-160.
3. Cordes, P., Sun, W., Wolber, R., Kolbe, L., Klebe, G., and Röhm, K.H. (2013). Expression in non-melanogenic systems and purification of soluble variants of human tyrosinase. Biol. Chem. 394, 685-693.
4. Das, B., Padma Rao, S., Srinivas, K.V.N.S., and Yadav, J.S. (1993). Stereospecific synthesis and absolute configuration of (+)-rhododendrol. Phytochemistry 33, 1529-1530.
5. Fushiya, S., Kabe, Y., Ikegaya, Y., and Takano, F. (1998). (+)-Rhododendrol and epi-rhododendrin suppress the NO production by activated macrophages in vivo. Planta Med. 64, 598-602.
6. Graham, D.G., Tiffany, S.M., Bell, W.R. Jr, and Gutknecht, W.F. (1978). Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
7. Ito, S., and Wakamatsu, K. (2008). Chemistry of mixed melanogenesis - Pivotal roles of dopaquinone. Photochem. Photobiol. 84, 582-592.
8. Ito, S., Nishigaki, A., Isii-Osai, Y. et al. (2012). Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models. Biochem. Pharmacol. 84, 646-653.
9. Ito, S., Yamashita, T., Ojika, M., and Wakamatsu, K. (2014). Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6, 7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity. Pigment Cell Melanoma Res. 27, 744-753.
10. Kolbe, L., Mann, W., Gerwat, W., Batzer, J., Ahlheit, S., Scherner, C., Wenck, H., and Stäb, F. (2013). 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. J. Eur. Acad. Dermatol. Venereol. 27(Suppl. 1), 19-23.
11. Manini, P., Napolitano, A., Westerhof, W., Riley, P.A., and d'Ischia, M. (2009). A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem. Res. Toxicol. 22, 1398-1405.
12. Ramsden, C.A., and Riley, P.A. (2014). Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. Bioorg. Med. Chem. 22, 2388-2395.
13. Sasaki, M., Kondo, M., Sato, K., Kawabata, K., Takahashi, Y., Suzuki, T., Matsunaga, K., and Inoue, S. (2014). Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism. Pigment Cell Melanoma Res. 27, 754-763.
14. Tallent, W.H. (1964). d-Betuligenol from Rhododendron maximum L. J. Org. Chem. 29, 988-989.
15. Wittbjer, A., Odh, G., Rosengren, E., and Rorsman, H. (1996). Enzymatic and non-enzymatic oxygenation of tyrosine. Pigment Cell Res. 9, 92-95.